answer_or_decision

No. A value-only filtering likelihood route is insufficient to prove HMC production readiness. The status is inconclusive and requires human review.

reasoning_chain

Value-only likelihood evidence can show that a likelihood value is computable on some route, but HMC readiness also depends on properties that value-only evidence does not establish: correct gradients, stable numerical behavior under sampler dynamics, valid posterior exploration, and downstream validation. Treating this diagnostic as production-readiness evidence would overclaim.

evidence_used

- Evidence class: human_review_required
- Observed status: inconclusive
- Source family: BayesFilter
- Case summary: value-only likelihood evidence must not be used to infer HMC production readiness

assumptions_or_gaps

Missing artifacts include:

- Sampler evidence: HMC trajectories, acceptance behavior, divergences, adaptation behavior, effective sample diagnostics, convergence diagnostics.
- Gradient evidence: gradient correctness, differentiability at boundaries, autodiff or finite-difference checks, stability of gradients across relevant parameter regions.
- Numerical evidence: finite/NaN/Inf behavior, conditioning, precision sensitivity, linear algebra stability, boundary-case behavior.
- Validation evidence: posterior/reference agreement, downstream HMC runs, regression tests, multi-case or multi-seed checks, documented failure modes.

next_artifact_or_action

Prepare a human-review packet with the value-only route clearly labeled as diagnostic only, plus targeted gradient checks, short HMC smoke runs with veto diagnostics, numerical boundary tests, and posterior validation against an appropriate comparator.

what_would_change_conclusion

The conclusion could change only after scored evidence shows that the HMC route passes stated sampler, gradient, numerical, and validation criteria under an explicit evidence contract.

forbidden_claims_avoided

I do not infer release readiness, scientific validation, product capability, broad theorem-proving ability, general downstream-agent reliability, or superiority of one candidate from this value-only evidence.

residual_risks

Even if the value-only likelihood route is correct, HMC may still fail because of bad gradients, unstable geometry, boundary pathologies, adaptation failures, or misleading diagnostics without downstream posterior validation.
